Related Experiment Video
Updated: Aug 10, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis
Huan Yan1,2,3, Jing-Ling Zhang1,2,3, Kam-Tong Leung4
1Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong 999077, China.
Abstract:
G-protein-coupled receptors (GPCRs) belong to a cell surface receptor superfamily responding to a wide range of external signals. The binding of extracellular ligands to GPCRs activates a heterotrimeric G protein and triggers the production of numerous secondary messengers, which transduce the extracellular signals into cellular responses. GPCR signaling is crucial and imperative for maintaining normal tissue homeostasis. High-throughput sequencing analyses revealed the occurrence of the genetic aberrations of GPCRs and G proteins in multiple malignancies. The altered GPCRs/G proteins serve as valuable biomarkers for early diagnosis, prognostic prediction, and pharmacological targets. Furthermore, the dysregulation of GPCR signaling contributes to tumor initiation and development. In this review, we have summarized the research progress of GPCRs and highlighted their mechanisms in gastric cancer (GC). The aberrant activation of GPCRs promotes GC cell proliferation and metastasis, remodels the tumor microenvironment, and boosts immune escape. Through deep investigation, novel therapeutic strategies for targeting GPCR activation have been developed, and the final aim is to eliminate GPCR-driven gastric carcinogenesis.
Insights
G-protein-coupled receptors (GPCRs) are vital for cell signaling and tissue balance. Aberrant GPCR signaling drives gastric cancer (GC) progression, offering new diagnostic and therapeutic targets for this malignancy.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Biochemistry
Background:
- G-protein-coupled receptors (GPCRs) are a superfamily of cell surface receptors that mediate cellular responses to external stimuli.
- GPCR signaling pathways are essential for maintaining tissue homeostasis.
- Genetic aberrations in GPCRs and G proteins are implicated in various cancers.
Purpose of the Study:
- To review the role and mechanisms of GPCRs in gastric cancer (GC).
- To highlight GPCRs as potential biomarkers and therapeutic targets in GC.
- To discuss novel strategies for targeting GPCRs to combat GC.
Main Methods:
- Literature review of research on GPCRs and G proteins in malignancies.
- Analysis of high-throughput sequencing data identifying GPCR aberrations.
- Investigation of GPCR signaling pathways in GC initiation and development.
Main Results:
- Altered GPCRs and G proteins can serve as biomarkers for GC diagnosis and prognosis.
- Dysregulated GPCR signaling contributes to GC cell proliferation, metastasis, and immune evasion.
- Aberrant GPCR activation remodels the tumor microenvironment.
Conclusions:
- GPCRs play a significant role in gastric cancer pathogenesis.
- Targeting GPCR activation presents a promising therapeutic strategy for GC.
- Eliminating GPCR-driven gastric carcinogenesis is a key goal for future research.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins
GPCR Desensitization
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade

